循环RNAs:PTEN表达和功能在癌症中的表观遗传调节者
Mohammad-Mojtaba Farazi1, Saeideh Jafarinejad-Farsangi2, Zahra Miri Karam3
1Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.
Gene
|April 6, 2024
概括
循环RNAs (circRNAs) 是新兴的表观遗传调节器,影响酸酶和张素同类物 (PTEN) 的表达. 了解circRNA-PTEN相互作用为癌症治疗提供了新的治疗途径.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 癌症研究 癌症研究
背景情况:
- 表观遗传调节控制基因表达而不改变DNA序列,影响细胞过程和癌症等疾病.
- 表观遗传学包括DNA甲基化,基因素修饰和调控性非编码RNA (ncRNA).
- 循环RNAs (circRNAs) 是最近被确定为重要的表观遗传调节者的一类ncRNAs.
研究的目的:
- 审查circRNAs在控制酸酶和张素同类素 (PTEN) 表达中的调节作用.
- 阐明PTEN的功能,一个关键的瘤抑制剂,在癌症途径中.
- 探索针对癌症中circRNA-PTEN相互作用的新型治疗策略.
主要方法:
- 关于circRNAs和PTEN的研究的文献综述.
- 在转录,后转录,翻译和后翻译层面分析circRNA调节.
- 检查PI3K/AKT通路在癌症中的作用和PTEN的参与.
主要成果:
- 循环RNAs通过多种调节机制调节PTEN表达.
- 通过抑制PI3K/AKT通路,PTEN作为瘤抑制剂,对癌细胞增殖和存活至关重要.
- 重要的研究突出了circRNAs和PTEN在瘤发生过程中的复杂关系.
结论:
- 循环RNAs是影响PTEN的表观遗传调节的重要组成部分.
- 了解circRNA-PTEN相互作用是破译PTEN瘤抑制功能的关键.
- 准circRNA-PTEN通路对开发创新的癌症疗法充满希望.
关键词:
癌症 癌症 癌症 癌症表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.在PI3K/AKT中使用.在这里,我们可以使用PTEN.圆形的RNAs是圆形的RNAs.这就是miRNAs.没有编码的RNAs.更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
6.9K
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
288
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:46Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K